BioMarin Pharmaceutical, Inc. (BMRN)
61.12
+0.55
(+0.91%)
USD |
NASDAQ |
Mar 06, 16:00
61.22
+0.10
(+0.16%)
After-Hours: 20:00
BioMarin Pharmaceutical SG&A Expense (TTM) : 1.153B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 383.49M |
| Gilead Sciences, Inc. | 8.398B |
| Merck & Co., Inc. | 10.73B |
| MannKind Corp. | 229.86M |
| AbbVie, Inc. | 14.01B |